Quarterly report pursuant to Section 13 or 15(d)

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.4.0.3
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Increase in cost of goods sold due to reclassification $ 86,291 $ 53,024  
Decrease in selling, general and administrative expenses (86,291) (53,024)  
Net loss (1,533,117) (2,648,809)  
Cash flows from operations (112,258) (2,582,851)  
Cash equivalents 0   $ 0
Cash in excess of FDIC limits 208,267    
Notes receivable 555,784   617,681
Allowance for doubtful accounts 100,000   100,000
Shipping and handling 86,291 53,024  
Allowance for customer returns 0 0  
Inventory 13,874,524   $ 14,133,920
Depreciation expense $ 49,025 $ 44,225  
Options [Member]      
Potentially dilutive shares outstanding 9,723,000 6,390,000  
Warrants [Member]      
Potentially dilutive shares outstanding 2,000,000    
Accounts Receivable [Member] | One Customer [Member]      
Concentration risk percentage 64.00%    
Accounts Receivable [Member] | Two Customers [Member]      
Concentration risk percentage     83.00%
Germany and The Netherlands [Member]      
Inventory $ 7,812,530    
Pharmaceutical Segment [Member]      
Capital required $ 1,500,000